Skip to main content

Table 2 Characteristics of asthmatic cases (allergic march phenotype and cough variant asthma phenotype)

From: Evaluation of serum levels of interferon beta and nucleotide binding and oligomerization domain 2 gene polymorphism in children with cough asthma phenotype: a case–control study

Characteristics of asthmatics

Allergic march (n = 60)

Cough variant asthma (n = 64)

P value

Duration of illness (years)

Median (min–max)

5.0 (0.50–12)

4.25 (1–16)

0.882

Degree of asthma severity

  

0.001*

 Mild

13 (21.7%)

9 (14.1%)

 

 Moderate

38 (63.3%)

55 (85.9%)

 

 Severe

9 (15.0%)

0 (0%)

 

Atopic dermatitis

  

 ≤ 0.001**

 Positive

60 (100.0%)

5 (7.8%)

 

 Negative

0 (0%)

59 (92.2%)

 

Allergic rhinitis

  

 ≤ 0.001**

 Positive

60 (100.0%)

15 (23.4%)

 

 Negative

0 (0%)

49 (76.6%)

 

History of controller medications

  

0.631

 ICS

2 (3.3%)

1 (1.6%)

 

 ICS and leukotriene

49 (81.7%)

56 (87.5%)

 

 Leukotriene modifier

9 (15.0%)

7 (10.9%)

 

Level of asthma control

  

0.544

 Controlled

22 (36.7%)

29 (45.3%)

 

 Partially controlled

13 (21.7%)

14 (21.9%)

 

 Severely uncontrolled

25 (41.7%)

21 (32.8%)

 
  1. * significant p ≤ 0.05
  2. ** highly significant p ≤ 0.001